Delivery Order SPE2DR25D1017-SPE2DR26F9BBK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) with a contract ceiling value of $12,962.44. This competitively awarded, firm fixed-price delivery order is set to conclude on October 30, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) valued at $2,944.08 under a firm fixed-price contract. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling and extends through December 2026. The award was competitively...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Nucynta ER 100 mg tablets in quantities of 60 units. This is a firm fixed price delivery order valued at $4,275.36 with an ultimate completion date of December 4, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) valued at $2,650.80. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to complete by October 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) with a contract ceiling value of $2,163.98. The award, issued on November 12, 2025, with an ultimate completion date of November 13, 2025, represents a non-competitive, non-set-aside delivery order executed under an existing contract vehicle. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Nucynta ER 50 mg tablets (60-count units) with a contract ceiling value of $2,812.92 and a firm fixed-price structure. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order is non-set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units) with a ceiling value of $1,110.11. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order contract valued at $2,281.90 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count units) on October 21, 2025, with completion scheduled for October 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,279.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Nucynta 100 mg tablets (100-count units) on December 5, 2025, with an ultimate completion date of December 8, 2025. This is a non-set-aside, competitively awarded contract with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger prime indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) with a ceiling value of $1,425.14. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is set to be completed by November 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BBKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) with a ceiling value of $2,850.28. This is a firm fixed-price delivery order under a competitive, non-set-aside procurement. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs within the Defense Health Agency and other government healthcare systems. The company's DLA contracts demonstrate extensive capability across multiple therapeutic domains, including pain management pharmaceuticals like the opioid analgesic Nucynta ER awarded in this delivery order. Place of performance is located at the contractor's corporate office in Conshohocken, PA, with an ultimate completion date of December 10, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 12/8/25 |